USA Regulatory ServicesMedReg provides medical device labeling support to help manufacturers ensure that their device labels, packaging, and accompanying documentation align with applicable U.S. FDA labeling requirements under 21 CFR Part 801 and other relevant regulations.
Our team assists manufacturers in reviewing, preparing, and updating medical device labelling to ensure that essential product information, intended use, instructions, and safety-related information are appropriately communicated to users.
What Is Medical Device Labelling?
Medical device labeling is an essential component of FDA regulatory compliance. Under 21 CFR Part 801, manufacturers and other responsible parties must ensure that applicable labeling requirements are met. Medical device labeling extends beyond the physical product label. It includes labels and other written, printed, or graphic information appearing on the device, its packaging, or accompanying materials.
FDA Guideline 21 CFR Part 801 establishes the general and device-specific labeling requirements that medical devices must meet to be marketed in the United States. The key provisions include:
- Section 801.1: Labeling must include the name and place of business of the manufacturer, packer, or distributor.
- Section 801.5: Directions for use must be adequate for the layperson or healthcare provider.
- Section 801.15: Labeling must be legible, prominent, and appropriately placed.
- Subpart B (801.20 – 801.57): Labeling requirements for Unique Device Identification (UDI).
- Subpart C (801.60 – 801.63): Labeling requirements for over-the-counter (OTC) devices; Subpart D (801.109 – 801.128): exemptions from adequate directions for use, including prescription devices (801.109).
The extent of labeling information required depends on the device’s risk classification and intended purpose. For instance, Class III implantable devices generally require more comprehensive labeling than low-risk Class I accessories. Certain devices may be exempt from adequate directions for use, such as prescription devices under 21 CFR 801.109 or devices for teaching, law enforcement, research and analysis under 21 CFR 801.125, subject to the applicable conditions related to their intended use and distribution.
FDA-Compliant Medical Device Labels general requirements
Medical device labels must contain adequate information to support the safe and effective use of the device. The essential labelling elements include:
- Device Identification and Intended Purpose: Clearly identify the medical device and specify its intended use.
- Instructions for Use (IFU): Provide step-by-step usage directions, including setup, maintenance, and disposal.
- Indications, Contraindications, and Precautions: Specify the intended patient population, circumstances in which the device should not be used, and relevant precautions.
- Warnings and Cautions: Communicate potential hazards and safety measures necessary to prevent harm arising from improper use.
- Manufacturer Information: Provide the manufacturer's name, address, and applicable contact details.
- Manufacture and Expiration Dates: Especially critical for sterile or time-sensitive products.
- Lot or Serial Number: for device information traceability
- Unique Device Identification (UDI): Include the required UDI information in accordance with applicable FDA requirements under 21 CFR Part 801, including § 801.40, where applicable. Refer to FDA UDI labelling requirements for detailed specifications.
- Standardized Symbols: Recognized medical device symbols, such as those specified in ISO 15223-1, may be used in accordance with applicable FDA requirements. Symbols that are not adequately recognized or understood may require accompanying explanations or a glossary, as applicable.
